EIKN
Eikon Therapeutics, Inc. Common Stock
NASDAQ: EIKN · HEALTHCARE · BIOTECHNOLOGY
$9.62
+5.54% today
Updated 2026-04-30
Market cap
$522.71M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.18
Dividend yield
—
52W range
$9 – $17
Volume
0.4M
Eikon Therapeutics, Inc. Common Stock (EIKN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating cash flow | $-190.85M | $-134.80M | $-188.52M |
| Capital expenditures | $28.51M | $84.80M | $46.74M |
| Depreciation | — | — | — |
| Stock-based comp | $9.54M | $12.43M | $18.04M |
| Free cash flow | $-219.36M | $-219.60M | $-235.26M |
| Investing cash flow | — | — | — |
| Financing cash flow | — | — | — |
| Dividends paid | — | — | — |
| Share repurchases | — | — | — |
| Debt repayment | — | — | — |
| Net change in cash | — | — | — |